Will the new Alzheimer’s drug put pressure on Medicare premiums?
The FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read MoreThe FDA approved the drug Leqembi, and Medicare will cover the new expensive new drug that promises the slowing the
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage enrollment has grown rapidly in recent years, now enrolling over half of
Read More(By Rylee Wilson for Becker’s Hospital Review) Nearly half of Medicare Advantage beneficiaries report having at least one health-related social
Read More(By Jakob Emerson for Becker’s Hospital Review) The Medicare Advantage star rating system and its quality bonus payment program is
Read More(By Rylee Wilson for Becker’s Hospital Review) Medicare Advantage profits will likely be stable in 2023 but could face pressure
Read More(By Jakob Emerson for Becker’s Hospital Review) There are major changes afoot for Medicare Advantage plans and when they are
Read More(By Rylee Wilson for Becker’s Hospital Review) Kaiser Permanente reduced rehospitalizations and deaths among Medicare Advantage members 30 days after
Read More(By Rylee Wilson for Becker’s Hospital Review) Cuts in Medicare Advantage benchmark payments did not lead to slower growth in
Read More(By Andrew Cass for Becker’s Hospital Review) More than 230 U.S. representatives and 61 senators are asking HHS and CMS
Read More(By Rylee Wilson for Becker’s Hospital Review) New York City Mayor Eric Adams is overriding the city comptroller’s attempt to
Read More